Advanced Diagnostic Testing Services

The Adult Metabolic, Wound Care & Healing Disorders Panel is an extensive genetic test aimed at identifying specific gene variations associated with a variety of health conditions covered under BH-MS plus vascular issues related to diabetes, and various wound care and healing disorders. 

The Autism Spectrum Disorders (ASD) Panel investigates genetic variations associated with autism spectrum disorders, encompassing 167 genes. ASD encompasses a range of conditions characterized by challenges in social interaction, communication, and behavior, affecting approximately 1 in 88 children. 

Eye Disorders and Retinopathies Panel investigates genetic variations linked to various eye disorders, including night blindness, color blindness, retinitis pigmentosa, nystagmus, age-related macular degeneration, cataracts, glaucoma, microphthalmia, severe vision reduction, and more, as documented at the end of this pamphlet. 

This panel identifies genetic factors that increase the risk of various cancers, including breast, ovarian, colon, prostate, melanoma and many more. This test examines inherited genetic variations (germline mutations) linked to a higher risk of cancer, enabling healthcare providers to personalize patient care.

This panel investigates genetic variations associated with type 1 and type 2 diabetes mellitus, potential genetic risk factors, and multi-organ complications. Diabetes mellitus (DM) is a metabolic disorder characterized by elevated blood glucose levels (hyperglycemia). Numerous genes have been identified to contribute to the lifetime risk of developing diabetes. 

The Musculoskeletal Disorders (Muscular) Panel examines genetic variations associated with various musculoskeletal disorders. This panel covers conditions such as limb-girdle muscular dystrophy, other types of muscular dystrophy, myopathies, rickets, chondrodysplasia, Ehlers-Danlos syndrome, Bethlem myopathy, Nemaline myopathy, osteogenesis imperfecta, and arthropathy. 

Neuro Panel analyzes genetic variations linked to various neurological disorders, including Alzheimer’s disease, frontotemporal dementia (FTD), Ataxia, Charcot-Marie-Tooth disease (CMT), spastic paraplegia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and epilepsy. 

Thyroid Disorders and Thyroid Cancer Panel investigates genetic variations associated with various thyroid-related conditions, including thyroid dyshormonogenesis, hyperthyroidism, hypothyroidism, thyroid cancers, hemochromatosis, and secondary reductions in thyroid hormone levels. 

(Conditions: Hyperlipidemia, Hypertension, Coronary Artery Disease, Diabetes, gout, porphyria, and hemochromatosis, Diabetic Vascular Disease). 

The Metabolic Syndrome Panel is an in-depth genetic test designed to identify gene variations linked to various health issues related to metabolic syndrome and cardiovascular disease risk. This panel specifically targets adult-onset metabolic disorders, including hypercholesterolemia, hyperlipidemia, hypertension, diabetes, coronary artery disease, gout, porphyria, and hemochromatosis. 

Focused on detecting mutations in genes that influence metabolic and inflammatory processes, this panel delivers precise insights into an individual’s genetic predisposition to these conditions. Disruptions in normal metabolism underpin these disorders, affecting how the body processes nutrients and energy. 

Hyperlipidemia: Refers to elevated levels of lipids (cholesterol and triglycerides) in the blood; caused by lifestyle factors or inherited conditions like FH.

Familial Hypercholesterolemia (FH): Agenetic disorder causing high LDL (“bad cholesterol”) from birth, leading to a higher risk of heart attacks and strokes if untreated.

Lipoprotein(a) [Lp(a)]: A genetically determined lipoprotein carrying cholesterol and fats; elevated levels increase the risk of atherosclerosis, heart attacks, and strokes.

Statins and Genetic Testing: Statins are commonly used to lower cholesterol, but genetic testing can identify individuals at risk of adverse effects, enabling safer and more effective treatment options.

Did you know that as a Medicare Part B recipient, you qualify for free genetics testing of your choice through our certified lab services. It is essential to prioritize your health, and genetic testing can provide valuable insights into potential health risks and personalized treatment options.

If you are interested in learning more about the genetics testing options available to you, please do not hesitate to reach out to our team at any time. Additionally, I encourage you to discuss with your doctor which specific test you would like to perform, as they can provide guidance based on your medical history and health goals.

Your health is of the utmost importance, and we want to ensure that you have access to the resources and information necessary to make informed decisions about your well-being. Whether you believe a particular genetics test is right for you or if you are simply curious about the options available, please feel free to contact us for more information.

Advancements in genetic science and coding are now accessible to the public. With genetic testing and mapping, we can precisely predict how medications will be metabolized in the body, and even identify which medication from a list is the best match for a patient’s unique physiology. This allows doctors to accurately and precisely determine both the short and long-term side effects of a medication on a patient’s body. If a medication is metabolized too quickly, the patient may not receive an adequate dosage. Conversely, if metabolism is too slow, the medication can accumulate and cause side effects. Personalized medicine, once a topic of fiction, is now a reality. Anyone with a genetic test and Family disease has access to personalized medication, ensuring they receive the most effective treatment tailored to their body’s needs. Thanks to new technology, pharmacogenetics is now an invaluable tool for doctors and patients seeking a safer and better quality of life.